Cannabis for female orgasmic disorder/difficulty: a systematic review
FOD/difficulty should be recognized as a qualifying condition for medical cannabis use. Given the existing evidence supporting its potential efficacy, medical cannabis warrants consideration as a first-line treatment. More randomized controlled trials are needed to clarify optimal dosing, routes of administration, strain specificity, timing of use, and differential effects across FOD subtypes.
Authors
- Suzanne Mulvehill (ORCID: https://orcid.org/0000-0002-4432-4934)
- Jordan Tishler (ORCID: https://orcid.org/0009-0008-7254-4089)
Institutions
- Federal Emergency Management Agency (US)
- Nia Association (US)
Publication Details
- Journal
- Sexual Medicine
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1093/sexmed/qfaf061
- Citations
- 1
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 1.39